Similar articles

• The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk.

  Gronchi A, Jones RL. Gronchi A, et al. JAMA Oncol. 2018 Sep 1;4(9):1167-1168. doi: 10.1001/jamaoncol.2018.1392. JAMA Oncol. 2018. PMID: 29879269 No abstract available.
• MRI assessment of surrounding tissues in soft-tissue sarcoma during neoadjuvant chemotherapy can help predicting response and prognosis.

  Crombé A, Le Loarer F, Stoeckle E, Cousin S, Michot A, Italiano A, Buy X, Kind M. Crombé A, et al. Eur J Radiol. 2018 Dec;109:178-187. doi: 10.1016/j.ejrad.2018.11.004. Epub 2018 Nov 5. Eur J Radiol. 2018. PMID: 30527301
• [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult].

  Mori S, Apice G, Ottaiano A, De Chiara A, Germano A, Botti G, De Rosa V, Ravo V, Morrica B, Mozzillo N. Mori S, et al. Tumori. 2003 Jul-Aug;89(4 Suppl):267-8. Tumori. 2003. PMID: 12903615 Italian. No abstract available.
• Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas.

  Scurr M, Judson I. Scurr M, et al. Hematol Oncol Clin North Am. 2005 Jun;19(3):489-500, vi. doi: 10.1016/j.hoc.2005.03.003. Hematol Oncol Clin North Am. 2005. PMID: 15939193 Review.
• The role of adjuvant chemotherapy in the treatment of adult soft tissue sarcomas.

  O'Byrne K, Steward WP. O'Byrne K, et al. Crit Rev Oncol Hematol. 1998 Apr;27(3):221-7. doi: 10.1016/s1040-8428(98)00004-3. Crit Rev Oncol Hematol. 1998. PMID: 9649934 Review. No abstract available.